Francesca Ceccherini-Silberstein at University of Rome Tor Vergata - Research Interests, Publications & Academic Profile

Francesca Ceccherini-Silberstein

University of Rome Tor Vergata

Italy

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Pakistani students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Virology

100%

Pharmacotherapy

30%

Antiviral Therapy

40%

Hiv

40%

Antiviral Research

30%

Hepatitis C

30%

Antiretroviral Therapy

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles11

Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile

Article Link

Year:

2022

The impact of DAA-mediated HCV eradication on CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort.

Article Link

Year:

2021

Alarming rates of virological failure and HIV‐1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY‐study in Cameroon

Article Link

Year:

2021

Resistance analysis and treatment outcomes in hepatitis C virus genotype 3‐infected patients within the Italian network VIRONET‐C

Article Link

Year:

2021

Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy

Article Link

Year:

2021

Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control

Article Link

Year:

2021

An increase in the levels of middle surface antigen characterizes patients developing hbv-driven liver cancer despite prolonged virological suppression

Article Link

Year:

2021

Virological response and resistance profile in highly treatment-experienced HIV-1-infected patients switching to dolutegravir plus boosted darunavir in clinical practice

Article Link

Year:

2021

HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients.

Article Link

Year:

2020

A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro

Article Link

Year:

2020

Cryptic HBV Replicative Activity Is Frequently Revealed in Anti-HBc-Positive/HBsAg-Negative Patients with HIV Infection by Highly Sensitive Molecular Assays, and Can Be Predicted by Integrating Classical and Novel Serological HBV Markers

Article Link

Year:

2020

Collaborators8

Teresa Pollicino

Full Professor

ITALY

Vincenzo Esposito

Head of Immunodeficiencies and Gender related Infectious Diseases

ITALY

Stefano Alcaro

ITALY

Julia Dietz

University Hospital Frankfurt

GERMANY

VALENTINA SVICHER

University of Rome Tor Vergata

ITALY

maria santoro

Assistant professor

University of Rome Tor Vergata

ITALY

ANDREA COSTANTINI

Assistant Professor of Clinical Immunology

Università Politecnica delle Marche

ITALY

Velia Chiara Di Maio

University of Rome Tor Vergata

ITALY

How do Pakistani students reach out?

Meet Kite AI